- Home
- SBS vs MEDP Comparison
SBS vs MEDP Comparison
Compare SBS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBS
- MEDP
- Stock Information
- Founded
- SBS 1954
- MEDP 1992
- Country
- SBS Brazil
- MEDP United States
- Employees
- SBS N/A
- MEDP N/A
- Industry
- SBS Water Supply
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SBS Utilities
- MEDP Health Care
- Exchange
- SBS Nasdaq
- MEDP Nasdaq
- Market Cap
- SBS 14.4B
- MEDP 13.4B
- IPO Year
- SBS 2002
- MEDP 2016
- Fundamental
- Price
- SBS $26.93
- MEDP $593.52
- Analyst Decision
- SBS
- MEDP Hold
- Analyst Count
- SBS 0
- MEDP 12
- Target Price
- SBS N/A
- MEDP $465.18
- AVG Volume (30 Days)
- SBS 1.1M
- MEDP 330.7K
- Earning Date
- SBS 11-10-2025
- MEDP 10-22-2025
- Dividend Yield
- SBS 2.04%
- MEDP N/A
- EPS Growth
- SBS N/A
- MEDP 25.36
- EPS
- SBS 1.98
- MEDP 14.32
- Revenue
- SBS $6,502,517,346.00
- MEDP $2,358,373,000.00
- Revenue This Year
- SBS N/A
- MEDP $21.48
- Revenue Next Year
- SBS $11.93
- MEDP $11.90
- P/E Ratio
- SBS $13.45
- MEDP $41.23
- Revenue Growth
- SBS N/A
- MEDP 13.88
- 52 Week Low
- SBS $13.87
- MEDP $250.05
- 52 Week High
- SBS $27.12
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- SBS 78.72
- MEDP 61.33
- Support Level
- SBS $25.35
- MEDP $573.07
- Resistance Level
- SBS $25.88
- MEDP $609.13
- Average True Range (ATR)
- SBS 0.42
- MEDP 17.50
- MACD
- SBS 0.18
- MEDP -2.71
- Stochastic Oscillator
- SBS 94.37
- MEDP 55.78
About SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.